LGC switches to renewable electricity in Germany

News (ZH) - From January 2022, the electricity we purchase for five of our sites in Germany - Augsburg, Berlin, Kulmbach, Luckenwalde and Wesel - will be generated from 100% renewable sources.

LGC appoints Vivid Sehgal as Chief Financial Officer

News (ZH) - Replaces Simon Parsons, who will leave LGC after 11 years of service

New LGC Chair in Measurement Science for Health appointed

News (ZH) - LGC has co-sponsored a new Chair in Measurement Science at the University of Strathclyde in Glasgow, UK, to help advance innovation in the medical, food and drink, and high-value manufacturing industries in the UK.

LGC reports half year trading in line with expectations

News (ZH) - Update for the half year ended 30 September 2021

LGC publishes ESG report for 2020-21

News (ZH) - LGC's first ESG report using GRI Standards, the most widely used sustainability reporting framework 

LGC to develop new Berlin site to expand Nucleic Acid Therapeutics capacity

News (ZH) - Site will be dedicated to medium to large scale and early to late Phase Clinical GMP manufacturing of Nucleic Acid Therapeutics

LGC’s commitment to carbon net zero

News (ZH) - LGC is committing to being carbon net zero by 2050

LGC supports British Pharmacopoeia 2022

博客 - LGC’s MHRA Laboratories Team supports the annual BP publication by providing physico-chemical analysis of substances

LGC, Biosearch Technologies testing workflow underpins expansion of COVID-19 testing in New York

News (ZH) - Nexar workflow continues to enable simple, scalable, and cost-effective testing 

LGC instruments support important milestones

博客 - LGC’s validated technology provides gold-standard sensitivity and specificity based on clinical data, as well as material cost and time savings.